The Liver Meeting 2021-COVID-19 in 2021: Hepatic Outcomes, Clinical Practice and Vaccine Updates

COVID-19 in 2021: Hepatic Outcomes, Clinical Practice and Vaccine Updates

Video Transcription

Video Summary

The video transcript summarizes the impact of COVID-19 on hepatology in 2021, focusing on updates regarding hepatic outcomes, clinical practice, and vaccination. The speakers addressed the challenges posed by the Delta variant, emphasized the importance of vaccination for patients with liver disease, and discussed monitoring systems for vaccine safety. They highlighted the need for booster doses for specific populations, such as liver transplant patients, and discussed long-term hepatic outcomes of COVID-19. The shift to telehealth services in hepatology, effects on clinical care and liver transplantation, and the impact on mental health and burnout of hepatology clinicians were also discussed. The transcript further delves into changes in hepatology practice during the pandemic, such as the increase in telemedicine visits and a decrease in in-person services, impacting the quality of care. Other topics included an increase in alcohol-associated liver disease patients wait-listed and transplanted, burnout among clinicians, vaccination strategies for liver transplant candidates, and the use of monoclonal antibodies for prevention and treatment.

Keywords

COVID-19

hepatology

Delta variant

vaccination

hepatic outcomes

clinical practice

monitoring systems

booster doses

telehealth services

liver transplantation

mental health

burnout

alcohol-associated liver disease